The Association Between XRCC3 Rs1799794 Polymorphism and Cancer Risk: a Meta-analysis of 34 Case-control Studies

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2021 May 1

PMID 33931047

Citations 4

Authors

Weiqing Liu

Shumin Ma

Lei Liang

Zhiyong Kou

Hongbin Zhang

Jun Yang

Affiliations

Soon will be listed here.

Abstract

Background: Studies on the XRCC3 rs1799794 polymorphism show that this polymorphism is involved in a variety of cancers, but its specific relationships or effects are not consistent. The purpose of this meta-analysis was to investigate the association between rs1799794 polymorphism and susceptibility to cancer.

Methods: PubMed, Embase, the Cochrane Library, Web of Science, and Scopus were searched for eligible studies through June 11, 2019. All analyses were performed with Stata 14.0. Subgroup analyses were performed by cancer type, ethnicity, source of control, and detection method. A total of 37 studies with 23,537 cases and 30,649 controls were included in this meta-analysis.

Results: XRCC3 rs1799794 increased cancer risk in the dominant model and heterozygous model (GG + AG vs. AA: odds ratio [OR] = 1.04, 95% confidence interval [CI] = 1.00-1.08, P = 0.051; AG vs. AA: OR = 1.05, 95% CI = 1.00-1.01, P = 0.015). The existence of rs1799794 increased the risk of breast cancer and thyroid cancer, but reduced the risk of ovarian cancer. In addition, rs1799794 increased the risk of cancer in the Caucasian population.

Conclusion: This meta-analysis confirms that XRCC3 rs1799794 is related to cancer risk, especially increased risk for breast cancer and thyroid cancer and reduced risk for ovarian cancer. However, well-designed large-scale studies are required to further evaluate the results.

Citing Articles

Potential Single Nucleotide Polymorphisms markers for radiation dermatitis in head and neck cancer patients: a meta-analysis.

Aguiar B, Ferreira E, Normando A, Dias S, Guerra E, Reis P Strahlenther Onkol. 2024; 200(7):568-582.

PMID: 38668865 DOI: 10.1007/s00066-024-02237-3.

Molecular Epidemiology in Amerindians of the Brazilian Amazon Reveals New Genetic Variants in DNA Repair Genes.

Cohen-Paes A, de Alcantara A, Moreira F, Fernandes M, Pantoja K, Carvalho D Genes (Basel). 2022; 13(10).

PMID: 36292754 PMC: 9601515. DOI: 10.3390/genes13101869.

, and Polymorphisms as Potential Predictive Biomarkers of Adjuvant Radiotherapy Toxicity in Early HER2-Positive Breast Cancer.

Goricar K, Dugar F, Dolzan V, Marinko T Cancers (Basel). 2022; 14(18).

PMID: 36139526 PMC: 9496855. DOI: 10.3390/cancers14184365.

Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis.

Hu S, Jing Y, Liu F, Han F Biomed Res Int. 2022; 2022:3915402.

PMID: 35978646 PMC: 9377891. DOI: 10.1155/2022/3915402.

References

Gresner P, Gromadzinska J, Polanska K, Twardowska E, Jurewicz J, Wasowicz W . Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer. Gene. 2012; 504(2):166-74. DOI: 10.1016/j.gene.2012.05.030. View

Zhao Y, Zhao E, Zhang J, Chen Y, Ma J, Li H . A Comprehensive Evaluation of the Association between Polymorphisms in , , and and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis. J Oncol. 2019; 2019:2408946. PMC: 6594280. DOI: 10.1155/2019/2408946. View

Winsey S, Haldar N, Marsh H, Bunce M, Marshall S, Harris A . A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res. 2000; 60(20):5612-6. View

Liu L, Miao L, Ji G, Qiang F, Liu Z, Fan Z . Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Mol Biol Rep. 2012; 40(6):3943-52. DOI: 10.1007/s11033-012-2471-5. View

Ma Q, Zhao Y, Wang S, Zhang X, Zhang J, Du M . Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies. Tumour Biol. 2013; 35(2):1473-80. DOI: 10.1007/s13277-013-1203-3. View

Tranah G, Giovannucci E, Ma J, Fuchs C, Hankinson S, Hunter D . XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2004; 13(6):1090-1. View

He F, Chang S, Wallar G, Zhang Z, Cai L . Association of XRCC3 and XRCC4 gene polymorphisms, family history of cancer and tobacco smoking with non-small-cell lung cancer in a Chinese population: a case-control study. J Hum Genet. 2013; 58(10):679-85. PMC: 4125205. DOI: 10.1038/jhg.2013.78. View

Qi L, Yu H, Zhang Y, Ding L, Zhao D, Lv P . A Comprehensive Meta-analysis of Genetic Associations Between Key Polymorphic Loci in DNA Repair Genes and Glioma Risk. Mol Neurobiol. 2016; 54(2):1314-1325. DOI: 10.1007/s12035-016-9725-5. View

Smolkova B, Dusinska M, Hemminki K . NBN and XRCC3 genetic variants in childhood acute lymphoblastic leukaemia. Cancer Epidemiol. 2014; 38(5):563-8. DOI: 10.1016/j.canep.2014.08.002. View

10.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

11.

Roukos D . Genome-wide association studies: how predictable is a person's cancer risk?. Expert Rev Anticancer Ther. 2009; 9(4):389-92. DOI: 10.1586/era.09.12. View

12.

Lau J, Ioannidis J, Schmid C . Quantitative synthesis in systematic reviews. Ann Intern Med. 1998; 127(9):820-6. DOI: 10.7326/0003-4819-127-9-199711010-00008. View

13.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

14.

Ali A, AbdulKareem H, Al Anazi M, Reddy Parine N, Shaik J, Alamri A . Polymorphisms in DNA Repair Gene XRCC3 and Susceptibility to Breast Cancer in Saudi Females. Biomed Res Int. 2016; 2016:8721052. PMC: 4736606. DOI: 10.1155/2016/8721052. View

15.

Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, Gamberini S . Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2005; 14(11 Pt 1):2569-78. DOI: 10.1158/1055-9965.EPI-05-0189. View

16.

Liu J, Tsai C, Hsu C, Chang W, Li C, Liu S . Contribution of double strand break repair gene XRCC3 genotypes to nasopharyngeal carcinoma risk in Taiwan. Chin J Physiol. 2015; 58(1):64-71. DOI: 10.4077/CJP.2015.BAD279. View

17.

Jacobsen N, Raaschou-Nielsen O, Nexo B, Wallin H, Overvad K, Tjonneland A . XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 2004; 213(1):67-72. DOI: 10.1016/j.canlet.2004.04.033. View

18.

Quaye L, Tyrer J, Ramus S, Song H, Wozniak E, Dicioccio R . Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS One. 2009; 4(6):e5983. PMC: 2695002. DOI: 10.1371/journal.pone.0005983. View

19.

Kuschel B, Auranen A, McBride S, Novik K, Antoniou A, Lipscombe J . Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet. 2002; 11(12):1399-407. DOI: 10.1093/hmg/11.12.1399. View

20.

Mishra A, Saxena S, Kaushal A, Nagaraju G . RAD51C/XRCC3 Facilitates Mitochondrial DNA Replication and Maintains Integrity of the Mitochondrial Genome. Mol Cell Biol. 2017; 38(3). PMC: 5770535. DOI: 10.1128/MCB.00489-17. View